102 related articles for article (PubMed ID: 22086684)
1. Elevated C-reactive protein level is associated with the tumor depth of invasion in patients with operable colorectal carcinoma.
Fujii T; Tabe Y; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Hepatogastroenterology; 2011; 58(110-111):1470-3. PubMed ID: 22086684
[TBL] [Abstract][Full Text] [Related]
2. Elevated C-reactive protein is associated with the tumor depth of invasion but not with disease recurrence in stage II and III colorectal cancer.
Fujii T; Yajima R; Tabe Y; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Hepatogastroenterology; 2013 Sep; 60(126):1343-7. PubMed ID: 23933927
[TBL] [Abstract][Full Text] [Related]
3. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer.
Lee JG; Cho BC; Bae MK; Lee CY; Park IK; Kim DJ; Ahn SV; Chung KY
Lung Cancer; 2009 Jan; 63(1):106-10. PubMed ID: 18513823
[TBL] [Abstract][Full Text] [Related]
4. Metastatic potential in T1 and T2 colorectal cancer.
Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
[TBL] [Abstract][Full Text] [Related]
5. [Clinical value of preoperative serum VEGF, CRP and IL-6 levels in colorectal carcinoma].
Li ZP; Han JQ; Meng XW; Yang YF
Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):795-9. PubMed ID: 21163075
[TBL] [Abstract][Full Text] [Related]
6. Elevation of C-reactive protein level is associated with synchronous and advanced colorectal neoplasm in men.
Chiu HM; Lin JT; Chen TH; Lee YC; Chiu YH; Liang JT; Shun CT; Wu MS
Am J Gastroenterol; 2008 Sep; 103(9):2317-25. PubMed ID: 18844617
[TBL] [Abstract][Full Text] [Related]
7. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphovascular invasion in sporadic colorectal cancer.
Lim SB; Yu CS; Jang SJ; Kim TW; Kim JH; Kim JC
Dis Colon Rectum; 2010 Apr; 53(4):377-84. PubMed ID: 20305435
[TBL] [Abstract][Full Text] [Related]
9. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
10. The risk of lymph node metastasis in T1 colorectal carcinoma.
Yamamoto S; Watanabe M; Hasegawa H; Baba H; Yoshinare K; Shiraishi J; Kitajima M
Hepatogastroenterology; 2004; 51(58):998-1000. PubMed ID: 15239233
[TBL] [Abstract][Full Text] [Related]
11. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.
Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC
Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250
[TBL] [Abstract][Full Text] [Related]
12. C-reactive protein is associated with distant metastasis of T3 colorectal cancer.
Ishizuka M; Nagata H; Takagi K; Kubota K
Anticancer Res; 2012 Apr; 32(4):1409-15. PubMed ID: 22493378
[TBL] [Abstract][Full Text] [Related]
13. The impact of preoperative serum C-reactive protein on the prognosis of patients with upper urinary tract urothelial carcinoma treated surgically.
Saito K; Kawakami S; Ohtsuka Y; Fujii Y; Masuda H; Kumagai J; Kobayashi T; Kageyama Y; Kihara K
BJU Int; 2007 Aug; 100(2):269-73. PubMed ID: 17488302
[TBL] [Abstract][Full Text] [Related]
14. Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.
Gakis G; Todenhöfer T; Renninger M; Schilling D; Sievert KD; Schwentner C; Stenzl A
BJU Int; 2011 Dec; 108(11):1800-5. PubMed ID: 21507193
[TBL] [Abstract][Full Text] [Related]
15. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of colorectal carcinoma in the elderly after radical surgery].
Liang JW; Bai XF; Zhou ZX; Zhao DB; Wang CF; Zhao P
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(21):1467-70. PubMed ID: 18953852
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
[TBL] [Abstract][Full Text] [Related]
18. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
Fang W; Fan B; Xiong B
Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
[TBL] [Abstract][Full Text] [Related]
19. Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer.
Crozier JE; McMillan DC; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McKee RF
J Gastroenterol Hepatol; 2007 Dec; 22(12):2288-91. PubMed ID: 18031394
[TBL] [Abstract][Full Text] [Related]
20. Prospective evaluation of prognostic factors in patients with colorectal cancer undergoing curative resection.
Fujita S; Shimoda T; Yoshimura K; Yamamoto S; Akasu T; Moriya Y
J Surg Oncol; 2003 Nov; 84(3):127-31. PubMed ID: 14598355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
